JPH0753728B2 - 抗精神病性縮合環ピリジニルピペラジン誘導体 - Google Patents

抗精神病性縮合環ピリジニルピペラジン誘導体

Info

Publication number
JPH0753728B2
JPH0753728B2 JP61103726A JP10372686A JPH0753728B2 JP H0753728 B2 JPH0753728 B2 JP H0753728B2 JP 61103726 A JP61103726 A JP 61103726A JP 10372686 A JP10372686 A JP 10372686A JP H0753728 B2 JPH0753728 B2 JP H0753728B2
Authority
JP
Japan
Prior art keywords
compound according
piperazinyl
butyl
pyridin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61103726A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61268681A (ja
Inventor
スチュアート ニュー ジェイムズ
ピー イエーヴィック ジョセフ
Original Assignee
ブリストル―マイアーズ スクイブ コムパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ブリストル―マイアーズ スクイブ コムパニー filed Critical ブリストル―マイアーズ スクイブ コムパニー
Publication of JPS61268681A publication Critical patent/JPS61268681A/ja
Publication of JPH0753728B2 publication Critical patent/JPH0753728B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP61103726A 1985-05-06 1986-05-06 抗精神病性縮合環ピリジニルピペラジン誘導体 Expired - Lifetime JPH0753728B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73120185A 1985-05-06 1985-05-06
US731201 1985-05-06

Publications (2)

Publication Number Publication Date
JPS61268681A JPS61268681A (ja) 1986-11-28
JPH0753728B2 true JPH0753728B2 (ja) 1995-06-07

Family

ID=24938510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61103726A Expired - Lifetime JPH0753728B2 (ja) 1985-05-06 1986-05-06 抗精神病性縮合環ピリジニルピペラジン誘導体

Country Status (25)

Country Link
JP (1) JPH0753728B2 (es)
KR (1) KR940000829B1 (es)
CN (1) CN1017901B (es)
AT (1) AT398572B (es)
AU (1) AU593244B2 (es)
BE (1) BE904724A (es)
CA (1) CA1278792C (es)
CH (1) CH672787A5 (es)
DE (1) DE3615180C2 (es)
DK (1) DK165745C (es)
EG (1) EG18206A (es)
ES (6) ES8801250A1 (es)
FI (1) FI85484C (es)
FR (1) FR2581385B1 (es)
GB (1) GB2174703B (es)
GR (1) GR861149B (es)
HU (1) HU195509B (es)
IE (1) IE59201B1 (es)
IT (1) IT1208607B (es)
LU (1) LU86421A1 (es)
MY (1) MY100777A (es)
NL (1) NL8601146A (es)
PT (1) PT82523B (es)
SE (1) SE465270B (es)
ZA (1) ZA862046B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
IE903410A1 (en) * 1989-10-09 1991-04-10 Novo Nordisk As Indole derivatives, their preparation and use
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
FR2738822B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
FR2738823B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique
FR2738824B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1 -yl)alkyl)-3,4-dihydroquinazolin-2(1h)-one,leur preparation et leur application en therapeutique
JP3335362B2 (ja) * 1995-09-15 2002-10-15 サノフィ―サンテラボ キノレイン−２（１ｈ）−オン誘導体セロトニンアンタゴニスト
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines

Also Published As

Publication number Publication date
GB2174703B (en) 1988-10-26
AU593244B2 (en) 1990-02-08
HU195509B (en) 1988-05-30
FI85484B (fi) 1992-01-15
DK165745C (da) 1993-06-14
DE3615180C2 (de) 1996-03-07
HUT43848A (en) 1987-12-28
GR861149B (en) 1986-09-09
IT1208607B (it) 1989-07-10
NL8601146A (nl) 1986-12-01
ES8900253A1 (es) 1989-05-16
ATA121486A (de) 1994-05-15
SE8602061D0 (sv) 1986-05-05
GB2174703A (en) 1986-11-12
ES8801250A1 (es) 1987-12-16
AU5679586A (en) 1986-11-13
LU86421A1 (fr) 1986-12-05
FI85484C (fi) 1992-04-27
ES554659A0 (es) 1987-12-16
FR2581385A1 (fr) 1986-11-07
CN86103071A (zh) 1987-03-18
GB8610810D0 (en) 1986-06-11
ES9000005A1 (es) 1989-11-01
ES557809A0 (es) 1988-09-01
ES557855A0 (es) 1989-05-16
PT82523A (en) 1986-06-01
ES8802149A1 (es) 1988-04-01
ZA862046B (en) 1986-11-26
SE465270B (sv) 1991-08-19
ES557757A0 (es) 1988-04-01
IE59201B1 (en) 1994-01-26
ES8900138A1 (es) 1989-01-16
ES557839A0 (es) 1989-01-16
FI861820A0 (fi) 1986-04-30
DK207186D0 (da) 1986-05-05
IE861193L (en) 1986-11-06
AT398572B (de) 1994-12-27
BE904724A (fr) 1986-11-05
MY100777A (en) 1991-02-14
SE8602061L (sv) 1986-11-07
FI861820A (fi) 1986-11-07
CH672787A5 (es) 1989-12-29
DK165745B (da) 1993-01-11
JPS61268681A (ja) 1986-11-28
DE3615180A1 (de) 1986-11-06
KR940000829B1 (ko) 1994-02-02
CN1017901B (zh) 1992-08-19
EG18206A (en) 1992-09-30
PT82523B (pt) 1988-10-14
ES8802614A1 (es) 1988-09-01
KR860009008A (ko) 1986-12-19
CA1278792C (en) 1991-01-08
FR2581385B1 (fr) 1991-10-04
DK207186A (da) 1986-11-07
IT8620313A0 (it) 1986-05-06

Similar Documents

Publication Publication Date Title
CA1285564C (en) 1-heteroaryl-4-¬(2,5-pyrrolidinedion-1-yl)alkyl|piperazine derivatives
US5001130A (en) Psychotropic heterobicycloalkylpiperazine derivatives
JPH0577669B2 (es)
JPH0753728B2 (ja) 抗精神病性縮合環ピリジニルピペラジン誘導体
US4677104A (en) Antipsychotic fused-ring pyridinylpiperazine derivatives
US4619930A (en) Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
US4880930A (en) Psychotropic acyclic amide derivatives
US4757073A (en) Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use
KR900002246B1 (ko) 테트라하이드로-2-헤테로사이클로알킬-피리도[4,3-b]인돌 및 그의 제조방법
US3706747A (en) Benzothieno(3,2-d)- and benzofuro(3,2-d)pyrimidines
JP2001501949A (ja) 中枢神経系疾患を処置することに有用な５―ヘテロ原子を含有するアルキル置換された―３―オキソ―ピリド（１，２―ａ）ベンゾイミダゾール―４―カルボキサミド誘導体
FI76794C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara spirotiazolidindionderivat.
JPH05247052A (ja) Ｎ−アルキルグルタールイミドの４−（４−ピペリジニル）−チエノ〔３，２−ｃ〕ピリジン誘導体
WO1996016057A1 (en) Certain 1-substituted aminomethyl imidazole and pyrrole derivatives; novel dopamine receptor subtype specific ligands
US12006301B1 (en) And synthesis of dual 5-HT1A and 5-HT7 receptor ligands
JPS584771A (ja) （５−アミノ−１，３−ジアルキルピラゾ−ル−４−イル）（アリ−ル）メタノンの塩基性アシルアミド類
US5116970A (en) Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
US5206365A (en) Psychotropic heterobicycloalkylpiperazine derivatives
JPH05345764A (ja) 新規アゼピン誘導体、その製造法およびその用途

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term